Skip to main content

19 August 2022

Last updated: Friday 19 August 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A good beginning in the perilous biotech business

Tuesday 26 October 2010

Interviewee/Contributor

Ingmar Hoerr

Organisation

CureVac GmbH

Organisations

Merck Serono Ventures
Novartis
4-Antibody AG
Massachusetts General Hospital
Novo Seeds
Eagle Genomics Ltd
ImmunoGen Inc
Janssen Oncology
Cellectis SA
Nanobiotix SA

Interviewees and Contributers

Marc Rogers
Koenraad Wiedhaup
Tim Van Hauwermeiren
Jean-Philippe Tripet
Philippe Pouletty
Antonin de Fougerolles
Ingmar Hoerr
Matthew Lakelin
Niall Martin and Jonathan Tobin
Chris Parker

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Catherine Isted appointed ReNeuron CEO

Thursday 4 August 2022

Thomas Schinecker to become Roche CEO

Wednesday 27 July 2022

Mark Leuchtenberger joins SpyBiotech

Sunday 17 July 2022

Andera Life Sciences appoints new partner

Sunday 17 July 2022

Anjarium appoints COO and CBO

Sunday 17 July 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form